DCs in lymphoma--biology and therapeutic aspects.
Schultze
J L
JL
Molecular Tumor Biology and Tumor Immunology, Internal Medicine I, Hematology and Oncology Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Fiore
F
F
von Bergwelt-Baildon
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology* / Q000637:transplantation*; D006801:Humans; D016219:Immunotherapy, Adoptive; D008223:Lymphoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines; D011948:Receptors, Antigen, T-Cell